SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
1. Signed and dated written informed consent in accordance with International Conference of Harmonisation-Good Clinical Practice (ICH-GCP) and local legislation prior to admission to the trial
2. Female (sex assigned at birth) with age \>18 years at the time of screening
3. History of at least one self-reported unsuccessful dietary effort to lose body weight
You may not be if
1. Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM)
2. Glycosylated Haemoglobin A1c (HbA1c) ≥6.5% (≥48 mmol/mol) as measured by the central laboratory at screening (Visit 1)
3. Treatment with any medication for the indication of obesity within 90 days before screening
Clareo Health | SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
